AMEREN CORP (AEE): what the price requires

At today's price, AMEREN CORP (AEE) is priced for -2.9% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/AEE

Headline

FieldValue
TickerAEE
CompanyAMEREN CORP
Current price$113.62/sh
CompositionAmeren Missouri 54% / Ameren Illinois Electric Distribution 27% / Ameren Illinois Natural Gas 11% / Ameren Transmission 8%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin today23.9%
Implied growth-2.9%
Multiple paid24x operating income

Solve inputs: computed at a 6.2% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~9.6pp.

Reconcile: at the x-ray's 9.3% required return this reads ~22.3%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.81σ
cohort percentile (of 70 peers)67
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.74x5expensive
Earnings1.89x3expensive
Relative1.29x5expensive
Growth1.11x2expensive

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.0%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——noReference only (OCF-based, capex excluded): OCF $3.3B
DCF Exit MultipleGrowth$0.00—noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$88.351.29xyesP/E 20x (static sector reference · 2026-04), scenarios: 16.3x / 20.0x / 23.7x (bear / base = reference held flat / bull), EV/EBITDA 16.4x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$105.981.07xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$59.371.91xyesBV/sh $48.69, ROE (TTM) 11.3%, ke 9.3%
Two-Stage Excess ReturnAsset$65.301.74xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$98.381.15xyesRev $8.9B, growth 13% (input: historical growth; tapered), Terminal P/S: 2.9x / 3.6x / 4.2x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$113.241.00xyesEPS $5.56, growth 20% (input: historical EPS growth), PEG=1.02 (Fair)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$10.6010.72xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.63B × (1−14%) / WACC 6.0% → EPV (no growth)
Residual IncomeAsset$66.461.71xyesBV $48.69 + 5yr PV of (ROE (TTM) 11.3% − Kₑ 9.3%) × BV; BV grows 7.3%/yr
Graham NumberAsset$78.051.46xyes√(22.5 × EPS $5.56 × BVPS $48.69) — Graham's conservative floor
EV/EBITDA RelativeRelative$26.934.22xyesEBITDA $2.13B × sector EV/EBITDA 13.0x
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$179.400.63xyesEPS $5.56 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$10.9910.34xyesBV $48.69 × (ROIC 1.4% / WACC 6.0%)
P/Sales SectorRelative$79.721.43xyesRevenue $8.88B × sector P/S 2.5x
PEG Fair ValueRelative$169.860.67xyesEPS $5.56 × (PEG 1.5 × growth 20.4% (input: historical EPS growth)) → PE 30.5x
Earnings YieldEarnings$60.111.89xyesEPS $5.56 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$21.3b
Net debt / NOPAT (after-tax)11.31x
Net debt / operating income (pre-tax)9.69x
Interest coverage2.8x
Share count CAGR (dilution)1.8%
Burning cashno

Bullet Takeaways

Ameren is a regulated electric and gas utility whose value lives in rate base, not in the income-statement growth a generic inversion measures. At $108.67 the price reads as paying about 23x company-wide operating income, but for a utility the right lens is the capital plan: management now points to a pipeline exceeding $70B through 2035, a roughly 10.6% rate-base CAGR, and EPS growth near the top of a 6% to 8% band.

The surprising part is the demand turn. After years of flat load, Ameren Missouri has signed 2.2 GW of data-center energy service agreements with another 1.2 GW in construction agreements expected to convert, which transforms the growth runway for a business that historically grew with population.

The constraint is the balance sheet and the regulator. Net debt is about $21.3B against operating income near $2.1B, interest coverage is only about 2.6x, and free cash flow is negative because the company is spending heavily on growth. Every dollar of that return depends on the Missouri and Illinois commissions approving the rates.

Bull Case

The counterintuitive finding sits right in the valuation math: the inversion reads Ameren as pricing in operating-profit growth of roughly negative 3.7% per year, yet the company is guiding to one of the strongest growth pipelines in its history. That apparent contradiction is the tell. A generic operating-income inversion penalizes a regulated utility because the company deliberately runs negative free cash flow, plowing capital into rate base faster than current earnings grow, and the payoff shows up later as an expanding regulated asset base earning an allowed return. Ameren's own filing frames the opportunity directly: "current industry projections reflect the potential for significant growth in energy demand over the next decade, primarily arising from data centers" (FY2025 10-K, accession 0001002910-26-000009). The number that matters is not this year's operating margin; it is the $70B-plus capital pipeline through 2035 and the roughly 10.6% rate-base CAGR it supports.

The second pillar is the load-growth inflection, which is real and contracted rather than hoped-for. Ameren Missouri has signed 2.2 GW of data-center energy service agreements, with an additional 1.2 GW of construction agreements expected to convert and 850 MW of agreements signed in downstate Illinois. For a utility whose earnings track rate base, large new customers that justify new generation and transmission are the cleanest possible growth: they expand the asset base on which the company earns its allowed return, and the incremental fixed-cost coverage can hold rates down for existing customers. Management has cited about $21M in projected base-rate savings over two years from committed data-center load, which is the political cover that makes the build approvable.

The third pillar is the regulated-return durability that underwrites the dividend. Ameren's filing describes recognizing "revenues for alternative revenue programs authorized by our regulators" and emphasizes "enhancing our regulatory frameworks" to support investment (FY2025 10-K). The mix is diversified across Ameren Missouri (54%), Ameren Illinois electric distribution (27%), Ameren Illinois natural gas (11%), and Ameren Transmission (8%), spreading regulatory risk across two states and multiple rate mechanisms. Q1 2026 EPS rose about 20% to $1.28, management reaffirmed 2026 guidance of $5.25 to $5.45, and the board raised the dividend to $0.71 quarterly. The valuation methods that capture rate-base growth, the two-stage DDM near $106 and the discounted future market cap near $94, sit close to or above the price.

Bear Case

The bear case for a utility is best framed through the cycle of capacity and capital, because that is where the fragility lives. Ameren is at the front end of an enormous build cycle, and the bear observation is that the demand it is building for, data-center load, is concentrated, new, and not yet fully de-risked. The filing's own cautionary language names the dependency: realizing the opportunity requires "our ability to realize and support forecasted energy demand and capacity from new and potential new customers" and obtaining "CCNs from the MoPSC or any other required approvals" (FY2025 10-K, accession 0001002910-26-000009). If hyperscaler capital plans slow, or if a few large customers renegotiate or delay, a utility that has committed billions of capex against that load is left with rate-base growth it must still earn a return on, and that return must come from someone's bill. The 2.2 GW of contracted load is a powerful tailwind, but it is also a customer-concentration risk of a kind utilities have not historically carried.

The second pressure is the balance sheet under a heavy capital program. Net debt is about $21.3B against trailing operating income near $2.1B, which is more than 10x, and interest coverage is only about 2.6x. Free cash flow is negative, meaning the entire build is funded by external debt and equity. Q1 2026 alone showed $421M of operating cash flow against $1.574B of capital expenditure. In a higher-for-longer rate environment, the cost of financing a $70B pipeline rises, and unlike an unregulated company, Ameren cannot simply raise prices to offset it; it must win rate relief from commissions on a regulatory lag. The Missouri rate case now under review will not set new base rates until mid-2027, so the company carries the financing cost of today's investment well before it earns the return.

The third issue is what the asset and earnings models say about the current price. The earnings-power value, which asks what the business is worth on current earnings with no growth, lands near $11.77 against the $108.67 price, and the ROIC-justified book value lands near $11.16, both reflecting a reported ROIC barely above 1% against a WACC near 6%. The excess-return and residual-income models land in the high $50s to high $60s. Those numbers do not say Ameren is worthless; they say the entire premium over book value is being paid for future rate-base growth that has not happened yet. The price sits in the upper half of the peer multiple range, so the market is already crediting the data-center story. If the build slips or the allowed returns compress, there is little valuation cushion.

Valuation

Ameren is a case where the headline inversion needs translation. At $108.67 the market is paying about 23x company-wide operating income, which a single solve reads as implying roughly negative 3.7% annual operating growth over five years at a 6.2% cost of capital. For most companies that would signal a price braced for decline; for a regulated utility deliberately running negative free cash flow to grow rate base, it mainly reflects that current operating income understates the earnings the asset base will produce as the capital plan converts to rate base. The reliability on this solve is rated low, and each percentage point of cost of capital swings the implied growth by nearly ten points, so the figure should be held loosely.

The model families show the usual utility split. The relative methods are mixed: sector P/E implies about $88 and P/S about $80, both below price, while the Ben Graham formula implies a much higher $179 on a low-yield input. The asset and earnings families are the conservative anchor, with excess-return and residual-income in the high $50s to high $60s, earnings-power value near $12, and ROIC-justified book near $11, all reflecting that reported returns on capital are below the cost of capital before the growth program matures.

The honest read is that Ameren is priced as a growth utility, not a value utility. The load-growth and rate-base story has to deliver to justify the premium over book and over current earnings power; the dividend, raised to $0.71 quarterly, is the cash return that pays the holder to wait for it.

Catalysts

Ameren reported Q1 2026 results in early May 2026 with EPS up about 20% to $1.28 and reaffirmed full-year 2026 guidance of $5.25 to $5.45 per share. The standout disclosure was the contracted load: 2.2 GW of data-center energy service agreements signed in Missouri, with another 1.2 GW of construction agreements expected to convert and 850 MW signed in Illinois, against a capital pipeline now exceeding $70B through 2035. Groundbreaking on existing agreements was anticipated in Q2 2026, which is the next visible milestone.

The load-bearing regulatory catalyst is the Missouri rate case. Ameren Missouri has filed for recovery of grid upgrades and new generation, and the Missouri Public Service Commission is running an 11-month review before new base rates take effect in mid-2027. The outcome, and the allowed return on equity it sets, is the single most important determinant of how much of the capital plan converts to earnings. Conversion of the 1.2 GW of construction agreements into firm energy service agreements is the other catalyst to watch.

Analyst sentiment has turned more constructive on the data-center thesis but is not unanimous. J.P. Morgan upgraded Ameren to Overweight with a $126 target citing AI data-center demand and the supportive Missouri setup, and BTIG initiated at a $131 target on large load growth, while Morgan Stanley trimmed its target to $110 at Equal Weight. The board raised the quarterly dividend to $0.71 ($2.84 annualized), continuing its long record of increases.

Peer Cohorts (Per Segment, With Filing Citations)

Ameren Missouri (reported)

Ameren Illinois Electric Distribution (reported)

Ameren Illinois Natural Gas (reported)

Ameren Transmission (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive AEE report on boothcheck